ArticlePloS one2015

Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease.

Md Shahaduzzaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.